54 studies found for:    Polymyositis
Show Display Options
Rank Status Study
21 Completed Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Conditions: Otorhinolaryngologic Disease;   Otorhinolaryngologic Neoplasm;   Pharyngeal Neoplasm;   Polymyositis;   Speech Disorder
Intervention:
22 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
Intervention:
23 Completed myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
Conditions: Polymyositis;   Dermatomyositis
Interventions: Other: transcriptome analysis;   Other: T cell repertoire analysis
24 Completed Anakinra in Myositis
Conditions: Polymyositis;   Dermatomyositis;   Inclusion Body Myositis
Intervention: Drug: Anakinra
25 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
Intervention:
26 Completed Genetic and Family Studies of Inherited Muscle Diseases
Conditions: Dermatomyositis;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type VII;   Myositis;   Polymyositis
Intervention:
27 Completed Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
Conditions: Rheumatoid Arthritis;   Polymyalgia Rheumatica;   Giant Cell Arteritis;   Polymyositis;   Wegener’s Granulomatosis
Intervention: Drug: Alendronate versus alfacalcidol (1-alpha OH vitamin D)
28 Recruiting Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Conditions: Myositis;   Polymyositis;   Dermatomyositis;   Myositis, Inclusion Body
Intervention: Procedure: MRI-oriented muscle biopsy
29 Completed Treatment With TNF Blockade, Infliximab, in Patients With Myositis
Condition: Refractory Myositis
Intervention: Drug: Infliximab
30 Not yet recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
31 Completed Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients
Conditions: Myositis;   Exercise
Intervention: Other: exercise
32 Unknown  Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emia
Condition: Pompe Disease
Intervention:
33 Unknown  A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
Condition: Idiopathic Inflammatory Myopathy
Intervention:
34 Unknown  Evaluating N-Acetylcysteine in CTD-ILD Treatment
Conditions: Interstitial Lung Disease;   Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
35 Completed Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Conditions: Autoimmune/Connective Tissue Diseases;   Idiopathic Inflammatory Myopathies;   IIM
Intervention:
36 Active, not recruiting A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Sifalimumab
37 Unknown  Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
38 Completed Mycophenolate Mofetil in Systemic Sclerosis
Condition: Diffuse Cutaneous Systemic Sclerosis
Intervention: Drug: Mycophenolate Mofetil
39 Recruiting Pulmonary Fibrosis Contact Registry
Conditions: Pulmonary Fibrosis of Any Cause;   Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis
Intervention:
40 Completed
Has Results
A Pilot Study of Etanercept in Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: Etanercept;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-54) Show next page of results
Indicates status has not been verified in more than two years